| 000 | 01008 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250518094219.0 | ||
| 264 | 0 | _c20201016 | |
| 008 | 202010s 0 0 eng d | ||
| 022 | _a1555-905X | ||
| 024 | 7 |
_a10.2215/CJN.02920320 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGaudreault-Tremblay, Marie-Michèle | |
| 245 | 0 | 0 |
_aBenefits of Continuing RAAS Inhibitors in Advanced CKD. _h[electronic resource] |
| 260 |
_bClinical journal of the American Society of Nephrology : CJASN _c05 2020 |
||
| 300 |
_a592-593 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Comment | ||
| 650 | 0 | 4 | _aAngiotensin-Converting Enzyme Inhibitors |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aRenal Insufficiency, Chronic |
| 650 | 0 | 4 | _aRenin-Angiotensin System |
| 700 | 1 | _aFoster, Bethany J | |
| 773 | 0 |
_tClinical journal of the American Society of Nephrology : CJASN _gvol. 15 _gno. 5 _gp. 592-593 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2215/CJN.02920320 _zAvailable from publisher's website |
| 999 |
_c30820763 _d30820763 |
||